Genetic Technologies Announces Completion of Share Transaction With Dr. Mervyn Jacobson
May 16, 2014 13:04 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - May 16, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced today the completion of a series of transactions with the Company's largest...
Genetic Technologies Files Activities Report for the Quarter Ended March 31, 2014
April 30, 2014 14:55 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Apr 30, 2014) - Genetic Technologies Limited (NASDAQ: GENE) (ASX: GTG) today announced it has filed its Quarterly Activities Report for the Quarter ended March...
Results From Extraordinary General Meeting
April 17, 2014 02:49 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Apr 17, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) advises that an Extraordinary General Meeting of shareholders was held at 10.00 am today...
Alchemia Announces Presentation of Data on Its Discovery of a Potential New Cancer Stem Cell Therapeutic Target During the 2014 AACR Annual Meeting
April 07, 2014 20:07 ET
|
Alchemia
BRISBANE, AUSTRALIA--(Marketwired - Apr 7, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that it will be presenting proprietary data at the American...
Genetic Technologies Executes Agreement With Promega Corporation
March 24, 2014 12:46 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Mar 24, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced today that in compliance with the ASX Continuous Disclosure Rules, the company...
Genetic Technologies Announces Publication of Economic Modeling Study Supporting Cost-Effectiveness of BREVAGen(TM) to Direct Tamoxifen Chemoprevention
March 07, 2014 05:15 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Mar 7, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) today announced the recent online publication in the journal Applied Health Economics and...
Alchemia to Present at the 26th Annual ROTH Conference on March 12, 2014
March 03, 2014 13:43 ET
|
Alchemia
BRISBANE, AUSTRALIA--(Marketwired - Mar 3, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that Thomas Liquard, the Company's Chief Executive Officer,...
Alchemia to Present at the Cowen and Company 34th Annual Health Care Conference on March 3, 2014
February 27, 2014 06:00 ET
|
Alchemia
BRISBANE, AUSTRALIA--(Marketwired - Feb 27, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that Thomas Liquard, the Company's Chief Executive Officer...
Genetic Technologies Provides Further Update on Corporate Structure
February 24, 2014 11:20 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Feb 24, 2014) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to advise that Ms. Alison Mew has confirmed that she will return to full-time...
Alchemia Appoints Thomas Liquard as Chief Executive Officer
February 24, 2014 06:00 ET
|
Alchemia
BRISBANE, AUSTRALIA--(Marketwired - Feb 24, 2014) - Alchemia Limited, (ASX: ACL) a drug discovery and development company, today announced the appointment of Thomas Liquard as Chief Executive...